Ovid Therapeutics Inc. (OVID) (CIK 0001636651) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001193125-25-327040
- Form
- CORRESP
- Filer
- Ovid Therapeutics Inc. (OVID) (CIK 0001636651)
- CIK
- 0001636651
- Ticker
- OVID
- Filed
- 2025-12-19
- SIC industry
- 2834
- HQ
- New York, NY
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1636651/000119312525327040/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗